Revathi Suppiah

Phase 2 Study of Pegylated Liposomal Doxorubicin, Vincristine, Decreased-Frequency Dexamethasone, and Thalidomide in Newly Diagnosed and Relapsed-Refractory Multiple Myeloma

Mohamad A. Hussein, Rachid Baz, Gordan Srkalović et al. · Mayo Clinic Proceedings · 2006 · 108 citations

Hematological Malignancy, Pegylated Liposomal Doxorubicin, Health Sciences +8

Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma

Revathi Suppiah, Philip Shaheen, Paul Elson et al. · Cancer · 2006 · 95 citations · Full text

Intraoperative scintigraphic localization and laparoscopic excision of accessory splenic tissue

Brendon J. Coventry, David I. Watson, Kirsty Tucker et al. · Surgical Endoscopy · 1998 · 31 citations

Laparoscopy, Minimally Invasive Procedure, Surgical Pathology +4

Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS)

Revathi Suppiah, Laura S. Wood, Paul Elson et al. · Investigational New Drugs · 2006 · 19 citations

Surgical Oncology, Malignant Disease, Phase I/ii Study +5

T regulatory cells (Treg) in patients with metastatic renal cell carcinoma (mRCC) decrease during sunitinib treatment: Correlations with clinical responses and T helper 1/T helper 2 (Th1/Th2) bias

Revathi Suppiah, James H. Finke, Brian I. Rini et al. · Journal of Clinical Oncology · 2006 · 15 citations

T-regulatory Cell, Immunology, Immunoediting +20